[u'-----BEGIN PRIVACY-ENHANCED MESSAGE-----\nProc-Type: 2001,MIC-CLEAR\nOriginator-Name: webmaster@www.sec.gov\nOriginator-Key-Asymmetric:\n MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen\n TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB\nMIC-Info: RSA-MD5,RSA,\n ExHMq7SJBkvFVb+ZVbwy0LnGUQsuwa63CrYZj8moeu8pdarINbd/hflgO8vjRh54\n n8FMK/aAK4Kjuh06+zvRWw==\n\n', u'0000950129-04-007105.txt : 20040916\n', u'0000950129-04-007105.hdr.sgml : 20040916\n', u'20040916121346\nACCESSION NUMBER:\t\t0000950129-04-007105\nCONFORMED SUBMISSION TYPE:\t8-K\nPUBLIC DOCUMENT COUNT:\t\t3\nCONFORMED PERIOD OF REPORT:\t20040915\nITEM INFORMATION:\t\tResults of Operations and Financial Condition\nITEM INFORMATION:\t\tFinancial Statements and Exhibits\nFILED AS OF DATE:\t\t20040916\nDATE AS OF CHANGE:\t\t20040916\n\nFILER:\n\n\tCOMPANY DATA:\t\n\t\tCOMPANY CONFORMED NAME:\t\t\tCYBERONICS INC\n\t\tCENTRAL INDEX KEY:\t\t\t0000864683\n\t\tSTANDARD INDUSTRIAL CLASSIFICATION:\tELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]\n\t\tIRS NUMBER:\t\t\t\t760236465\n\t\tSTATE OF INCORPORATION:\t\t\tDE\n\t\tFISCAL YEAR END:\t\t\t0630\n\n\tFILING VALUES:\n\t\tFORM TYPE:\t\t8-K\n\t\tSEC ACT:\t\t1934 Act\n\t\tSEC FILE NUMBER:\t000-19806\n\t\tFILM NUMBER:\t\t041033199\n\n\tBUSINESS ADDRESS:\t\n\t\tSTREET 1:\t\t100 CYBERONICS CENTER BLVD\n\t\tSTREET 2:\t\tSUITE 600\n\t\tCITY:\t\t\tHOUSTON\n\t\tSTATE:\t\t\tTX\n\t\tZIP:\t\t\t77058\n\t\tBUSINESS PHONE:\t\t(281) 228-7200\n\n\tMAIL ADDRESS:\t\n\t\tSTREET 1:\t\t100 CYBERONICS  BLVD\n\t\tSTREET 2:\t\tSUITE 600\n\t\tCITY:\t\t\tHOUSTON\n\t\tSTATE:\t\t\tTX\n\t\tZIP:\t\t\t77058\n', u'\n', u'\n', u'8-K\n', u'1\n', u'h18481e8vk.htm\n', u'CYBERONICS, INC. - DATED 9/15/2004\n', u'\n', u'e8vk', u'\n', u' PAGEBREAK ', u'\n', u'Table of Contents', u'\n', u'\n', u'\n', u'\n', u'UNITED STATES', u'\nSECURITIES AND EXCHANGE COMMISSION', u'\n', u'Washington, D.C. 20549', u'\n', u'\n', u'FORM 8-K', u'\n', u'CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D)', u'\nOF THE SECURITIES EXCHANGE ACT OF 1934', u'\n', u'Date of Report (Date of Earliest Event Reported): September\xa015, 2004', u'\n', u'CYBERONICS, INC.', u'\n', u'(Exact name of registrant as specified in its charter)', u'\n', u'\n', u'\n', u' Begin Table Head ', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' End Table Head ', u'\n', u' Begin Table Body ', u'\n', u'\n', u'Delaware', u'\n(State or other', u'\njurisdiction of', u'\nincorporation)\n', u'\n', u'\xa0', u'\n', u'0-19806', u'\n(Commission', u'\nfile number)\n', u'\n', u'\xa0', u'\n', u'76-0236465', u'\n(IRS Employer', u'\nIdentification No.)', u'\n', u'\n', u' End Table Body ', u'\n', u'\n', u'\n', u'Cyberonics Building', u'\n100 Cyberonics Boulevard', u'\nHouston, Texas 77058', u'\n(Address of principal executive offices) (Zip code)\n\n\n\n', u'(281)\xa0228-7200', u'\nRegistrant\x92s telephone number, including area code:\n\n\n\n', u'\n', u'\n', u'\n', u'\xa0\n', u'\n', u' PAGEBREAK ', u'\n', u'\n', u'\n', u' TOC ', u'\n', u'TABLE OF CONTENTS', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'\n', u'Item\xa02.02 Results of Operations and Financial Condition', u'\n', u'Item\xa09.01 Financial Statements and Exhibits', u'\n', u'SIGNATURE', u'\n', u'Press Release dated September 15, 2004', u'\n', u'\n', u'\n', u' /TOC ', u'\n', u'\n', u'Table of Contents', u'\n', u' link2 "Item&nbsp;2.02 Results of Operations and Financial Condition" ', u'\n', u'\n', u'Item\xa02.02 Results of Operations and Financial Condition', u'\n', u'\xa0\xa0\xa0\xa0\xa0On September\xa015, 2004, Cyberonics, Inc. (\x93Company\x94) issued a press release\nannouncing that the Company\x92s Board of Directors, after consulting with its\nfinancial advisor, Merrill Lynch & Co., has unanimously rejected Advanced\nNeuromodulation Systems Inc.\x92s invitation to \x93meet to discuss a business\ncombination.\x94 The Company also conducted a conference call during which it\ndiscussed the press release. A copy of the press release is attached as an\nexhibit.\n\n\n', u'\xa0\xa0\xa0\xa0\xa0In accordance with General Instruction B.2. of Form 8-K, the Press Release\nattached hereto as Exhibit\xa099.1 shall not be deemed \x93filed\x94 for purposes of\nSection\xa018 of the Securities Exchange Act of 1934, as amended, nor shall it be\ndeemed incorporated by reference in any filing under the Securities Act of\n1933, as amended, except as shall be expressly set forth by specific reference\nin such a filing.\n\n', u' link2 "Item&nbsp;9.01 Financial Statements and Exhibits" ', u'\n', u'\n', u'Item\xa09.01 Financial Statements and Exhibits', u'\n', u'\xa0\xa0\xa0\xa0\xa0(c)\xa0Exhibits\n\n\n\n', u'99.1\xa0\xa0\xa0\xa0\xa0Press Release of Cyberonics, Inc. dated as of September\xa015, 2004.\n\n', u' link1 "SIGNATURE" ', u'\n', u'\n', u'SIGNATURE', u'\n', u'\xa0\xa0\xa0\xa0\xa0Pursuant to the requirements of the Securities Exchange Act of 1934, the\nRegistrant has duly caused this report to be signed on its behalf by the\nundersigned thereunto duly authorized.\n\n', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'CYBERONICS, INC.', u'\n\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'/s/ David S. Wise\n\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'David S. Wise\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\xa0', u'\n', u'Vice President, General Counsel and Secretary\xa0', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Date: September\xa016, 2004\n\n\n\n', u'\xa0\n', u'\n', u' PAGEBREAK ', u'\n', u'\n', u'Table of Contents', u'\n', u'\n', u'EXHIBIT LIST', u'\n', u'\xa0\xa0\xa0\xa0\xa099.1\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Press Release of Cyberonics, Inc. dated as of September\xa015, 2004.\n\n\n', u'\xa0\n', u'\n', u'\n', u'\n', u'\n', u'EX-99.1\n', u'2\n', u'h18481exv99w1.htm\n', u'PRESS RELEASE DATED SEPTEMBER 15, 2004\n', u'\n', u'exv99w1', u'\n', u' PAGEBREAK ', u'\n', u'\xa0', u'\n', u'\n', u'\n', u'Exhibit\xa099.1', u'\n', u'For Immediate Release Wednesday, September\xa015, 2004\n\n\n\n', u'CYBERONICS REITERATES NO INTEREST IN ANY MERGER OR COMBINATION WITH', u'\nADVANCED NEUROMODULATION SYSTEMS\n\n\n\n', u'Conference call at 4:30 PM EDT today, September\xa015', u'\n', u'HOUSTON, Texas, September\xa015, 2004 \x97 Cyberonics, Inc. (NASDAQ:CYBX) today\nannounced that its Board of Directors, after consulting with its financial\nadvisor, Merrill Lynch & Co., has unanimously rejected Advanced\nNeuromodulation Systems Inc.\x92s (NASDAQ:ANSI) invitation to \x93meet to discuss\na business combination.\x94 The Company reconfirms its previously stated\nposition in its press release dated August\xa020, 2004, that it is not\ninterested in any combination or merger and remains focused on strengthening\nits epilepsy business and gaining clarity and certainty in a revised\ndepression regulatory plan and timeline.\n\n', u'CONFERENCE CALL ACCESS INFORMATION\n\n', u'A conference call to discuss this press release will be held at 4:30 PM EDT\ntoday, Wednesday, September\xa015, 2004. To listen to the conference call live by\ntelephone dial 877-451-8943 (if dialing from within the U.S.) or 706-679-3062\n(if dialing from outside the U.S.). The conference ID is 210644; the leader is\nPam Westbrook. A replay of the conference call will be available two hours\nafter the completion of the conference call on Wednesday, September\xa015, 2004\nthrough Wednesday, September\xa029, 2004 by dialing 800-642-1687 (if dialing from\nwithin the U.S.) or 706-645-9291 (if dialing outside the U.S.). The replay\nconference ID access code is 210644.\n\n', u'ABOUT VNS THERAPY AND CYBERONICS\n\n\n', u'Cyberonics, Inc. (NASDAQ:CYBX) was founded in 1987 to design, develop and\nmarket medical devices for the long-term treatment of epilepsy and other\nchronic neurological disorders using a unique therapy, vagus nerve\nstimulation (VNS). Stimulation is delivered by the VNS Therapy System, an\nimplantable generator similar to a cardiac pacemaker. The VNS Therapy\nSystem delivers preprogrammed intermittent mild electrical pulses to the\nvagus nerve 24 hours a day. The Company\x92s initial market is epilepsy, which\nis characterized by recurrent seizures. Epilepsy is the second most\nprevalent neurological disorder. The Cyberonics VNS Therapy System was\napproved by the FDA on July\xa016, 1997 for use as an adjunctive therapy in\nreducing the frequency of seizures in adults and adolescents over 12\xa0years\nof age with partial onset seizures that are refractory to antiepileptic\nmedications. The VNS Therapy System is also approved for sale as a\ntreatment for epilepsy in all the member countries of the European Economic\nArea, Canada, Australia and other markets. To date, more than 27,000\nepilepsy patients in 24 countries have accumulated over 79,000 patient years\nof experience using VNS Therapy. The VNS Therapy System is approved for\nsale in the European Economic Area and in Canada as a treatment for\ndepression in patients with treatment-resistant or treatment-intolerant\nmajor depressive episodes including unipolar depression and bipolar disorder\n(manic depression). VNS Therapy is at various levels of investigational\n', u'\xa0\n', u'\n', u' PAGEBREAK ', u'\n', u'\n', u'\xa0', u'\n', u'\n', u'clinical study as a potential treatment for depression, anxiety disorders,\nAlzheimer\x92s disease, and chronic headache/migraine. The Company is\nheadquartered in Houston, Texas and has an office in Brussels, Belgium. For\nadditional information please visit us at www.cyberonics.com.\n\n', u'CONTACT INFORMATION', u':', u'\n', u'\n', u'\n', u' Begin Table Head ', u'\n', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\xa0', u'\n', u'\n', u' End Table Head ', u'\n', u' Begin Table Body ', u'\n', u'\n', u'Pamela B. Westbrook\n', u'\n', u'\xa0', u'\n', u'Helen Shik', u'\n', u'\n', u'\n', u'Vice President of Finance and CFO\n', u'\n', u'\xa0', u'\n', u'Vice President', u'\n', u'\n', u'\n', u'Cyberonics, Inc.\n', u'\n', u'\xa0', u'\n', u'Schwartz Communications', u'\n', u'\n', u'\n', u'100 Cyberonics Blvd.\n', u'\n', u'\xa0', u'\n', u'230 Third Avenue', u'\n', u'\n', u'\n', u'Houston, TX 77058\n', u'\n', u'\xa0', u'\n', u'Waltham, MA 02154', u'\n', u'\n', u'\n', u'Main: (281)\xa0228-7200\n', u'\n', u'\xa0', u'\n', u'Main: (781)\xa0684-0770 ext. 6587', u'\n', u'\n', u'\n', u'Fax: (281)\xa0218-9332\n', u'\n', u'\xa0', u'\n', u'Fax: (781)\xa0684-6500', u'\n', u'\n', u'\n', u'pbw@cyberonics.com\n', u'\n', u'\xa0', u'\n', u'hshik@schwartz-pr.com', u'\n', u'\n', u' End Table Body ', u'\n', u'\n', u'\n', u'*\xa0\xa0\xa0\xa0\xa0*\xa0\xa0\xa0\xa0\xa0*\n\n\n\n\n', u'\xa0\n', u'\n', u'\n', u'\n', u'\n', u'GRAPHIC\n', u'3\n', u'h18481h1848146.gif\n', u'GRAPHIC\n', u'\nbegin 644 h18481h1848146.gif\nM1TE&.#EAS0!>`/OS[_.C4*8@VAL2=PNWB\nM[(8TA^3.+))\'CHP^@8Y"?IA2=:EN9,"43K:"6?OX^I!$?84Q@:UUJH,NBNO9\nM)L"6OM*TT,:@P[N-N-6YU.S;)>G:Z-S%V]"M/_CT^-"QSK![K>K7)YU;FHHY\nMA9E3E88T@M:V.KR0NL>=2', u'ZH]"BZ=J9X(M?M2XTJ1F:?/J\\GXIC-BY..WK', u'G(P_@)E2\nM', u'(_W]_8@W\nMAOW\\_._?(N[>(O[]_?_^__S\\_/#A(?#B(?+J\\?\'C\'[!Y7?[__H0PBO+I\\88T\nMB)%\'>__^_O\'B(>S?Z]2S.^[?(_GP&/CS^/+C(($KB^[=)/;O]>[?(MB]J-_)\nMW;:#6/[]^.W@[-_*W=>W.H8QB/[___[^_;)[78DXA,>?2-"OSO___LFA1_GX\nM^;R,4^73Y)M7E^74Y,&14/#?(\\2;2L6?P\\RE1+.`6H@UA+%Z7_OY^X0NBMO$\nMVL*73;B\'M?#C((DXA?___R\'Y!```````+`````#-`%X```C_`/\\)\'$BPH,\nM"!,J7,BPH', u"/($.*'$FRI,F3*$", u'G%0QYS\nMMY1JW9I4E@8E4\\.*S;@[^B7-.F90JFCHZQ', u"/':6L(BF]R_\nM", u"DG(=GISV5JXD>AIK3GFLTUW*H+FJ:+!XL^F0\nMCR6'7BVZ$-C3L#528&&!M>VM*E+", u'R!\\N*A%\\N\',5\nM+^(DGYY0R(7FSIU;2(&\'NO>!%*YG_Q^/U$*K+M^I&V"%G;SV3B/2(Z]UH[![\nM][ELQ9#?^TT#U?>1-UHF_,&V1@SM!:C="5L4N-DS?`"HH\'MMS.&@9FLD8=2$\nM]XU&PH6`T\\8$8UR*%;%BB>[`LD8:*-3R058"Y2)A6$R45!*,"#BHA0(H\nMG`1SA1S^^`*!(X;4X(MAN^P0!#(BL)\'4+2@\\H8HQO(3*"Q(9J%.`\'US9DHL,\nM?_8TC`\\,3/^300%H;NK*.9Z8,`FJC@*1@3R%YE5I&+IDFA0"JP2#!#``B"&/\nM-!\\@8', u'Y.)-!,0!L@D"C$+BA3082,(K7\nML,5J>M0"97(RQ2FNC+O`#BMP4DP+U]1ZE`4G#+(M2L+D\\8HQV.0P[E8U!,#)\nM!Z=@M8LICG@B32[K\'N7\'#CFL4`6JN#6PPJ#)SC5\'B!\nMCG1@V)%:S`%`KH!', u'$2DUD$', u'XS7_.IG+ZZH:0(,,`:Z\nM-*$ZT43G(+3HQ3]H00N!X`(7!,$\'/@2BC%H,@Y,"$00H"8*+6FQ2D\\_X!3$Z\nM*8Q?/.,?O>AD+O^!"P-HLB#X/\\,3"VBY', u'(`$W("-1$2!\nM*]O9S4\'.H`$\\0.$?T2!!#_@@44C\\@P#\'J$4V(`$#`>R&KU`A""0`(8`B^(D/\nM&I`!\'?Y!`C+P,AP3QZ]`\\.;\'81/]"I&A1Q@R3_*.`?\nM&P!+`OR2@)^V-@$*Z"0CTD"!?]2!J3(@[3_N@`MF)"`&:Y#!5052BP0(J082\nM,$8&`E``9,1-CA;TH5)R`0H3K+4%LS"B_?`BAR=8HP_T$`5>6P$\'A,`@!J6)\nM0Q:R0"`!&):O[U@$8QW[CU\\0X`CC\'UC@AA+C%/>Z+\nM=5I:7,"`!#H`A`:FN\\E,V.', u')0X5:`&!BL#*`[@"#\',PFMM`,.%#X((/[TA_PY*T($\'1!P*#6A@H?]`Z#S>\nMD6=^_(`0!.&"GWJPT$C(@!6`YH(+\\+`39J2APRR(`0BNRHH.."$^KOT\';*N!\nMA3T((!.1\\(`7")!9$DPX"])QP6TUH-,1$->X3!5"!]#1`841@@2T4$`\'B#P,\nM+!SY*`ZX`A*F$$@`."!X25&G4K)B"FP4XP`B.``TC/5(`*B"$OI$BAS&4`Q.\nMJ*.12L\'6*!&"2F\'\\LA?"$`@F2$$0(4SX\'[400G$)LDM:K*$6REC#*-*-BU[,\nM4B`46*6^M_D/`PAAE?^F13%QD4D#*%P@:Q""*_\\A"&UIJ\\"N?\'B!55J*B]-B\nME?,V2#9J=81D("-4\'_]H`9637=;AK7Q39S-!$((1C&)0>Q/L``.', u',(7J/")``S!`>-/RFBXH!!]&-;Z#J\'%C;1RA#XJ"`4U("6V\nML2,WA1!Z4`>O@7\\-P0A+0#U#8ANYH`*`H!"$H`],I8`-@0LL\\&L/J!WN,`,*\nM40=JAX$.H0,.F!8.,`244`4(@`(/4`%34P`?Y`"4L((+D`LUT`@%`"`X6`\'K\nMDD$%\\`', u'W@``5P`[R(%_S-`G)\nMT`T1`+:X(&-I`(U[``SI`(*Q`(C>*-5#`!/.#^`T', u'>_P\'XG99?Z0!:ND$\'Q0!)(7F1`Q#-\'@#K+CE[8@\nM"7?@$!Z0`)XY$=EP"2CPEK:0`GBV$+30`ZJYFA-1"UN0`J,Y)+:0"ATP;@MA\nM!\'$`#KAI$4+``F*9\';`0"]V1@81@68%$/(03M4`0B):`?@0M*4`>6T`J(R14H\nM(`MYP`KOT)D3(0"6`(P4*A(&L`%', u'G>:+?\nM,0,LP`P.JJ.]80!.,`]`ZAU8NAFXH`!%D``=$`E=6J:`40OK0`>0X`&7@``%W%`+[(FHDCJI\n(E%JIFQ$0`#L_\n`\nend\n\n', u'\n', u'\n', u'\n-----END PRIVACY-ENHANCED MESSAGE-----\n']